An Exploratory, Double-Blinded, Randomized, Pharmacokinetic and Safety Study of Three Rectally-Applied Tenofovir 1% Microbicide Gel Formulations
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2015
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 07 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Feb 2013 Planned end date changed from 1 Apr 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.